Abstract
Biobank-scale sequencing studies have enabled the analysis of rare variants contributing to complex traits. We introduce MetaSTAARlite, a scalable and resource-efficient summary statistics-based pipeline for functionally-informed rare variant meta-analysis in both the coding and noncoding genome, bypassing the data-sharing restrictions of pooled analysis using individual-level data across multiple biobanks. Using the sequencing data of UK Biobank and the All of Us Research Program, we demonstrate that MetaSTAARlite’s computation time, memory, and storage requirements scale linearly with sample size, while producing results highly concordant with those of a pooled analysis.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by the research start-up funds from the Department of Biostatistics at the University of North Carolina at Chapel Hill (Y.K. and X.L.).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
UK Biobank: Ethical approval was granted by the National Research Ethics Service Committee North West, Haydock (Reference Number: 11/NW/0382). Detailed information can be found here: https://www.ukbiobank.ac.uk/media/cs1h15s3/rtb-nwrec-application-and-approval-2011.pdf. This RTB approval was granted initially in 2011 and it is renewal on a 5-yearly cycle: hence UK Biobank successfully applied to renew it in 2016 and 2021. All of Us: The study was approved by the Institutional Review Board of the All of Us Research Program. Detailed information can be found here: https://allofus.nih.gov/about/who-we-are/institutional-review-board-irb-of-all-of-us-research-program.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability
The UK Biobank analyses data were obtained under applications 52008, 91486 and 211447. The functional annotation data are publicly available at the Functional Annotation of Variant-Online Resource (FAVOR)7 site (https://favor.genohub.org) and the FAVOR database (https://doi.org/10.7910/DVN/1VGTJI). All of Us phenotype data and exome data can be accessed through the All of Us research workbench (https://workbench.researchallofus.org), publicly available to registered researchers with controlled tier access.
